These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


257 related items for PubMed ID: 33187908

  • 1. Forkhead box O1-mediated ubiquitination suppresses RIG-I-mediated antiviral immune responses.
    Ma Z, Zhang W, Fan W, Wu Y, Zhang M, Xu J, Li W, Sun L, Liu W, Liu W.
    Int Immunopharmacol; 2021 Jan; 90():107152. PubMed ID: 33187908
    [Abstract] [Full Text] [Related]

  • 2. Cyclophilin A-regulated ubiquitination is critical for RIG-I-mediated antiviral immune responses.
    Liu W, Li J, Zheng W, Shang Y, Zhao Z, Wang S, Bi Y, Zhang S, Xu C, Duan Z, Zhang L, Wang YL, Jiang Z, Liu W, Sun L.
    Elife; 2017 Jun 08; 6():. PubMed ID: 28594325
    [Abstract] [Full Text] [Related]

  • 3. TRIM9 short isoform preferentially promotes DNA and RNA virus-induced production of type I interferon by recruiting GSK3β to TBK1.
    Qin Y, Liu Q, Tian S, Xie W, Cui J, Wang RF.
    Cell Res; 2016 May 08; 26(5):613-28. PubMed ID: 26915459
    [Abstract] [Full Text] [Related]

  • 4. RACK1 attenuates RLR antiviral signaling by targeting VISA-TRAF complexes.
    Xie T, Chen T, Li C, Wang W, Cao L, Rao H, Yang Q, Shu HB, Xu LG.
    Biochem Biophys Res Commun; 2019 Jan 15; 508(3):667-674. PubMed ID: 30527812
    [Abstract] [Full Text] [Related]

  • 5. TRIM25 and DEAD-Box RNA Helicase DDX3X Cooperate to Regulate RIG-I-Mediated Antiviral Immunity.
    Atkinson SC, Heaton SM, Audsley MD, Kleifeld O, Borg NA.
    Int J Mol Sci; 2021 Aug 23; 22(16):. PubMed ID: 34445801
    [Abstract] [Full Text] [Related]

  • 6. LRRC59 modulates type I interferon signaling by restraining the SQSTM1/p62-mediated autophagic degradation of pattern recognition receptor DDX58/RIG-I.
    Xian H, Yang S, Jin S, Zhang Y, Cui J.
    Autophagy; 2020 Mar 23; 16(3):408-418. PubMed ID: 31068071
    [Abstract] [Full Text] [Related]

  • 7. CD97 negatively regulates the innate immune response against RNA viruses by promoting RNF125-mediated RIG-I degradation.
    Chang H, Hou P, Wang X, Xiang A, Wu H, Qi W, Yang R, Wang X, Li X, He W, Zhao G, Sun W, Wang T, He DC, Wang H, Gao Y, He H.
    Cell Mol Immunol; 2023 Dec 23; 20(12):1457-1471. PubMed ID: 37978243
    [Abstract] [Full Text] [Related]

  • 8. SRA Suppresses Antiviral Innate Immune Response in Macrophages by Limiting TBK1 K63 Ubiquitination via Deubiquitinase USP15.
    Li L, Luo J, Zhu Z, Xu Q, Wang P, Chang B, Wang D, Yu L, Lu X, Zhou J, Zuo D, Chen Q.
    Microbiol Spectr; 2022 Dec 21; 10(6):e0202822. PubMed ID: 36342281
    [Abstract] [Full Text] [Related]

  • 9. Targeting PRMT7-mediated monomethylation of MAVS enhances antiviral innate immune responses and inhibits RNA virus replication.
    Yang J, Li W, Zhang Z, Gong X, Chen Y, Peng X, Hu G, Dai X, He Y, Huang Y, Cao S, Yang Y, Liu W.
    Proc Natl Acad Sci U S A; 2024 Nov 19; 121(47):e2408117121. PubMed ID: 39546576
    [Abstract] [Full Text] [Related]

  • 10. TRAF7 negatively regulates the RLR signaling pathway by facilitating the K48-linked ubiquitination of TBK1.
    Huang JP, Yang YX, Chen T, Wang DD, Li J, Xu LG.
    Virol Sin; 2023 Jun 19; 38(3):419-428. PubMed ID: 37086853
    [Abstract] [Full Text] [Related]

  • 11. 5-methylcytosine (m5C) RNA modification controls the innate immune response to virus infection by regulating type I interferons.
    Zhang Y, Zhang LS, Dai Q, Chen P, Lu M, Kairis EL, Murugaiah V, Xu J, Shukla RK, Liang X, Zou Z, Cormet-Boyaka E, Qiu J, Peeples ME, Sharma A, He C, Li J.
    Proc Natl Acad Sci U S A; 2022 Oct 18; 119(42):e2123338119. PubMed ID: 36240321
    [Abstract] [Full Text] [Related]

  • 12. Porcine epidemic diarrhea virus (PEDV) ORF3 protein inhibits cellular type I interferon signaling through down-regulating proteins expression in RLRs-mediated pathway.
    Zheng L, Liu H, Tian Z, Kay M, Wang H, Cheng L, Xia W, Zhang J, Wang W, Cao H, Xu X, Gao Z, Geng R, Wu Z, Zhang H.
    Res Vet Sci; 2023 Jun 18; 159():146-159. PubMed ID: 37148734
    [Abstract] [Full Text] [Related]

  • 13. The double-stranded RNA-dependent protein kinase PKR negatively regulates the protein expression of IFN-β induced by RIG-I signaling.
    Matsumiya T, Shiba Y, Ding J, Kawaguchi S, Seya K, Imaizumi T.
    FASEB J; 2023 Feb 18; 37(2):e22780. PubMed ID: 36651716
    [Abstract] [Full Text] [Related]

  • 14. DDX5 inhibits type I IFN production by promoting degradation of TBK1 and disrupting formation of TBK1 - TRAF3 complex.
    Zhang Y, Cen J, Yuan G, Jia Z, Chen K, Gao W, Chen J, Adamek M, Jia Z, Zou J.
    Cell Mol Life Sci; 2023 Jul 18; 80(8):212. PubMed ID: 37462751
    [Abstract] [Full Text] [Related]

  • 15. Riok3 inhibits the antiviral immune response by facilitating TRIM40-mediated RIG-I and MDA5 degradation.
    Shen Y, Tang K, Chen D, Hong M, Sun F, Wang S, Ke Y, Wu T, Sun R, Qian J, Du Y.
    Cell Rep; 2021 Jun 22; 35(12):109272. PubMed ID: 34161773
    [Abstract] [Full Text] [Related]

  • 16. Involvement of zebrafish RIG-I in NF-κB and IFN signaling pathways: insights into functional conservation of RIG-I in antiviral innate immunity.
    Nie L, Zhang YS, Dong WR, Xiang LX, Shao JZ.
    Dev Comp Immunol; 2015 Jan 22; 48(1):95-101. PubMed ID: 25265425
    [Abstract] [Full Text] [Related]

  • 17. The E3 ligase ASB3 downregulates antiviral innate immunity by targeting MAVS for ubiquitin-proteasomal degradation.
    Cheng M, Lu Y, Wang J, Wang H, Sun Y, Zhao W, Wang J, Shi C, Luo J, Gao M, Yu T, Wang J, Guan J, Wang N, Yang W, Jiang Y, Huang H, Yang G, Cao X, Yang D, Wang C, Zeng Y.
    Cell Death Differ; 2024 Dec 22; 31(12):1746-1760. PubMed ID: 39266719
    [Abstract] [Full Text] [Related]

  • 18. The antiviral activity of myricetin against pseudorabies virus through regulation of the type I interferon signaling pathway.
    Song Y, Zhao X, Chen Y, Yu X, Su T, Wang J, He T, Yin Z, Jia R, Zhao X, Zhou X, Li L, Zou Y, Li M, Zhang D, Zhang Y, Song X.
    J Virol; 2024 Nov 27; ():e0156724. PubMed ID: 39601590
    [Abstract] [Full Text] [Related]

  • 19. SARS-CoV-2 NSP7 inhibits type I and III IFN production by targeting the RIG-I/MDA5, TRIF, and STING signaling pathways.
    Deng J, Zheng Y, Zheng SN, Nan ML, Han L, Zhang J, Jin Y, Pan JA, Gao C, Wang PH.
    J Med Virol; 2023 Mar 27; 95(3):e28561. PubMed ID: 36755358
    [Abstract] [Full Text] [Related]

  • 20. [Knockout of RIG-I in HEK293 cells by CRISPR/Cas9].
    Chen Z, Wu Y, Zhang Y, Gao Y.
    Sheng Wu Gong Cheng Xue Bao; 2024 Nov 25; 40(11):4254-4265. PubMed ID: 39584349
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.